Overview of Lefax
| Property | Description |
|---|---|
| Active ingredient | Simethicone |
| Form | Oral suspension (drops/liquid), Chewable tablets, Soft capsules |
| Pharmacological class | Gastrointestinal agent (Antiflatulent) |
| Common use | Relief of gas, bloating, and feeling of fullness |
| Origin | Synthetic (Silicone compound) |
What is Lefax and What Class Does it Belong To?
Lefax is a recognized trade name for an over-the-counter medicine designed for the relief of gastrointestinal discomfort caused by excess gas. Its single active ingredient, Simethicone, belongs to the miscellaneous GI agents class, specifically recognized as an antiflatulent. This monopreparation is primarily intended to manage the pressure and pain that arise from gas trapped within the digestive system. Simethicone's non-systemic mode of action is a distinguishing feature; the substance is not absorbed into the bloodstream but performs its function entirely within the stomach and intestines.
Simethicone: Origin, Composition, and Available Forms
The active ingredient Simethicone is a stable, synthetic silicone compound—specifically a mixture of polydimethylsiloxanes and silica gel. The brand is often known for its oral suspension form, commonly referred to as drops or liquid, which is specifically formulated for infants and younger children, differentiating it from adult-focused preparations. To suit various patient needs, Lefax is also manufactured in chewable tablets and soft capsules for oral administration. Simethicone acts locally in the gastrointestinal tract to disrupt the foam layer, which results in a minimal risk of systemic side effects.
How Does Lefax Provide General Relief?
Lefax provides general relief by physically assisting the body in the removal of gas that is trapped within the gastrointestinal tract, which can occur after consuming certain foods. It alleviates symptoms such as uncomfortable bloating, abdominal fullness, and pressure from meteorism. The compound acts as a surfactant to reduce the high surface tension of the numerous small, persistent foam bubbles that impede gas passage. By causing these bubbles to coalesce into larger, free gas pockets, the medication facilitates the easier and more natural expulsion of the gas, resolving the physical source of the patient’s discomfort. Simethicone's defoaming action is a functional approach for symptomatic relief of excess gas.
Regulatory References


